Genomate helps oncologists determine the optimal targeted therapy for every cancer patient based on the individual molecular profile of their tumor. Unlike currently available solutions, Genomate can combine what we know about the unique combination of genetic alterations found in every patient to make an automated inference about the right personalized therapy.

Genomate helps oncologists determine the optimal targeted therapy for every cancer patient based on the individual molecular profile of their tumor. Unlike currently available solutions, Genomate can combine what we know about the unique combination of genetic alterations found in every patient to make an automated inference about the right personalized therapy.

Instead of reporting cancer gene–treatment associations and related pieces of evidence individually, the system automatically combines all information from thousands of pieces of evidence associated with the totality of genetic alterations in an individual tumor to create a simple score in 20 milliseconds.

The output is a personalized report, which provides oncologists with a list of recommended drugs and treatment options tailored to the individual patient's molecular profile. This way, oncologists can enhance their decision-making process and deliver more effective targeted therapies to their patients.